Skip to main content
The BMJ logoLink to The BMJ
. 2003 Oct 11;327(7419):0.

Trial results have dramatically reduced HRT use

PMCID: PMC213997

The publication of the combined oestrogen-progestogen trial from the Women's Health Initiative, which generated extensive media coverage in 2002, has affected women's decisions to use hormone replacement therapy (HRT). In a cross sectional survey of women attending general practices in New Zealand, Lawton and colleagues (p 845) investigated the effect of the publication on the use of HRT in known users. Over half of those surveyed had stopped taking HRT, and stopping was significantly associated with increasing age, use of combined HRT, and use for more than five years. The authors say that women sought appropriate advice from health professionals and that stopping HRT was in line with recommendations in international guidelines.

Figure 1.

Figure 1


Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES